AAPL297.01-1.00 (-0.34%) ▼|ABBV230.01+13.52 (+6.25%) ▲|ABT87.83-0.58 (-0.66%) ▼|ACN124.83-3.15 (-2.46%) ▼|ADBE194.90-0.26 (-0.13%) ▼|AMAT640.18+23.07 (+3.74%) ▲|AMD551.63+14.26 (+2.65%) ▲|AMGN344.72+7.12 (+2.11%) ▲|AMT176.43+0.38 (+0.22%) ▲|AMZN232.79-11.60 (-4.75%) ▼|AVGO392.13-19.22 (-4.67%) ▼|AXP338.07+0.07 (+0.02%) ▲|BA220.83-1.89 (-0.85%) ▼|BAC57.37+1.17 (+2.08%) ▲|BKNG167.77-4.01 (-2.33%) ▼|BLK1,051.74+1.65 (+0.16%) ▲|BMY54.70+0.70 (+1.30%) ▲|BNY146.44+2.81 (+1.96%) ▲|BRK-B488.69-0.77 (-0.16%) ▼|C145.67+2.61 (+1.82%) ▲|CAT1,022.28+36.46 (+3.70%) ▲|CL88.67-0.81 (-0.91%) ▼|CMCSA22.32-0.11 (-0.49%) ▼|COF200.70-0.83 (-0.41%) ▼|COP109.70+1.96 (+1.82%) ▲|COST951.35-0.10 (-0.01%) ▼|CRM150.12-1.66 (-1.09%) ▼|CSCO121.53+1.99 (+1.66%) ▲|CVS101.30+2.98 (+3.03%) ▲|CVX175.06+1.43 (+0.82%) ▲|DE598.59+9.35 (+1.59%) ▲|DHR178.19+1.02 (+0.58%) ▲|DIS102.45-1.44 (-1.39%) ▼|DUK123.52-0.34 (-0.27%) ▼|EMR150.21-0.45 (-0.30%) ▼|FDX328.78+3.80 (+1.17%) ▲|GD343.36-6.65 (-1.90%) ▼|GE355.12-2.52 (-0.70%) ▼|GEV1,127.59+17.86 (+1.61%) ▲|GILD124.87+1.11 (+0.90%) ▲|GM80.43+1.14 (+1.44%) ▲|GOOG348.78-18.68 (-5.08%) ▼|GOOGL349.68-18.35 (-4.99%) ▼|GS1,106.37+9.81 (+0.89%) ▲|HD326.62-7.66 (-2.29%) ▼|HON228.11-0.90 (-0.39%) ▼|IBM252.22+3.12 (+1.25%) ▲|INTC140.94+6.95 (+5.19%) ▲|INTU257.77-9.23 (-3.46%) ▼|ISRG402.95-3.83 (-0.94%) ▼|JNJ231.29+2.90 (+1.27%) ▲|JPM331.48+6.26 (+1.92%) ▲|KO79.53+0.14 (+0.18%) ▲|LIN516.71+4.56 (+0.89%) ▲|LLY1,102.08+3.51 (+0.32%) ▲|LMT493.60-17.35 (-3.40%) ▼|LOW214.40-7.80 (-3.51%) ▼|LRCX409.54+20.50 (+5.27%) ▲|MA484.09-5.70 (-1.16%) ▼|MCD270.10-8.51 (-3.05%) ▼|MDLZ59.51-0.61 (-1.01%) ▼|MDT79.27-0.07 (-0.09%) ▼|META563.85-13.37 (-2.32%) ▼|MMM163.22+2.62 (+1.63%) ▲|MO69.51+0.39 (+0.56%) ▲|MRK115.48+1.61 (+1.41%) ▲|MS227.09+3.92 (+1.76%) ▲|MSFT367.34-12.06 (-3.18%) ▼|MU1,211.38+77.39 (+6.82%) ▲|NEE86.08-0.67 (-0.77%) ▼|NFLX72.88-4.50 (-5.82%) ▼|NKE43.19-2.01 (-4.45%) ▼|NOW93.01-2.03 (-2.14%) ▼|NVDA208.65-2.04 (-0.97%) ▼|ORCL175.07-9.22 (-5.00%) ▼|PEP140.71-1.31 (-0.92%) ▼|PFE25.08-0.13 (-0.52%) ▼|PG147.68-2.70 (-1.80%) ▼|PLTR119.50-8.97 (-6.98%) ▼|PM173.17-5.23 (-2.93%) ▼|QCOM221.90-4.21 (-1.86%) ▼|RTX181.83-3.77 (-2.03%) ▼|SBUX100.15-0.50 (-0.50%) ▼|SCHW92.03+0.33 (+0.36%) ▲|SO93.43+0.34 (+0.37%) ▲|SPG214.57+3.24 (+1.53%) ▲|T22.10+0.09 (+0.41%) ▲|TMO464.01-0.60 (-0.13%) ▼|TMUS180.06-1.61 (-0.89%) ▼|TSLA405.05+4.56 (+1.14%) ▲|TXN332.28+9.42 (+2.92%) ▲|UBER71.43-0.21 (-0.29%) ▼|UNH406.68+5.72 (+1.43%) ▲|UNP259.91+3.03 (+1.18%) ▲|UPS107.24+2.38 (+2.27%) ▲|USB58.68+0.54 (+0.93%) ▲|V326.60-0.64 (-0.20%) ▼|VZ45.36-0.01 (-0.02%) ▼|WFC83.84+1.64 (+2.00%) ▲|WMT117.18+0.00 (+0.00%) ▲|XOM138.47+0.66 (+0.48%) ▲|AAPL297.01-1.00 (-0.34%) ▼|ABBV230.01+13.52 (+6.25%) ▲|ABT87.83-0.58 (-0.66%) ▼|ACN124.83-3.15 (-2.46%) ▼|ADBE194.90-0.26 (-0.13%) ▼|AMAT640.18+23.07 (+3.74%) ▲|AMD551.63+14.26 (+2.65%) ▲|AMGN344.72+7.12 (+2.11%) ▲|AMT176.43+0.38 (+0.22%) ▲|AMZN232.79-11.60 (-4.75%) ▼|AVGO392.13-19.22 (-4.67%) ▼|AXP338.07+0.07 (+0.02%) ▲|BA220.83-1.89 (-0.85%) ▼|BAC57.37+1.17 (+2.08%) ▲|BKNG167.77-4.01 (-2.33%) ▼|BLK1,051.74+1.65 (+0.16%) ▲|BMY54.70+0.70 (+1.30%) ▲|BNY146.44+2.81 (+1.96%) ▲|BRK-B488.69-0.77 (-0.16%) ▼|C145.67+2.61 (+1.82%) ▲|CAT1,022.28+36.46 (+3.70%) ▲|CL88.67-0.81 (-0.91%) ▼|CMCSA22.32-0.11 (-0.49%) ▼|COF200.70-0.83 (-0.41%) ▼|COP109.70+1.96 (+1.82%) ▲|COST951.35-0.10 (-0.01%) ▼|CRM150.12-1.66 (-1.09%) ▼|CSCO121.53+1.99 (+1.66%) ▲|CVS101.30+2.98 (+3.03%) ▲|CVX175.06+1.43 (+0.82%) ▲|DE598.59+9.35 (+1.59%) ▲|DHR178.19+1.02 (+0.58%) ▲|DIS102.45-1.44 (-1.39%) ▼|DUK123.52-0.34 (-0.27%) ▼|EMR150.21-0.45 (-0.30%) ▼|FDX328.78+3.80 (+1.17%) ▲|GD343.36-6.65 (-1.90%) ▼|GE355.12-2.52 (-0.70%) ▼|GEV1,127.59+17.86 (+1.61%) ▲|GILD124.87+1.11 (+0.90%) ▲|GM80.43+1.14 (+1.44%) ▲|GOOG348.78-18.68 (-5.08%) ▼|GOOGL349.68-18.35 (-4.99%) ▼|GS1,106.37+9.81 (+0.89%) ▲|HD326.62-7.66 (-2.29%) ▼|HON228.11-0.90 (-0.39%) ▼|IBM252.22+3.12 (+1.25%) ▲|INTC140.94+6.95 (+5.19%) ▲|INTU257.77-9.23 (-3.46%) ▼|ISRG402.95-3.83 (-0.94%) ▼|JNJ231.29+2.90 (+1.27%) ▲|JPM331.48+6.26 (+1.92%) ▲|KO79.53+0.14 (+0.18%) ▲|LIN516.71+4.56 (+0.89%) ▲|LLY1,102.08+3.51 (+0.32%) ▲|LMT493.60-17.35 (-3.40%) ▼|LOW214.40-7.80 (-3.51%) ▼|LRCX409.54+20.50 (+5.27%) ▲|MA484.09-5.70 (-1.16%) ▼|MCD270.10-8.51 (-3.05%) ▼|MDLZ59.51-0.61 (-1.01%) ▼|MDT79.27-0.07 (-0.09%) ▼|META563.85-13.37 (-2.32%) ▼|MMM163.22+2.62 (+1.63%) ▲|MO69.51+0.39 (+0.56%) ▲|MRK115.48+1.61 (+1.41%) ▲|MS227.09+3.92 (+1.76%) ▲|MSFT367.34-12.06 (-3.18%) ▼|MU1,211.38+77.39 (+6.82%) ▲|NEE86.08-0.67 (-0.77%) ▼|NFLX72.88-4.50 (-5.82%) ▼|NKE43.19-2.01 (-4.45%) ▼|NOW93.01-2.03 (-2.14%) ▼|NVDA208.65-2.04 (-0.97%) ▼|ORCL175.07-9.22 (-5.00%) ▼|PEP140.71-1.31 (-0.92%) ▼|PFE25.08-0.13 (-0.52%) ▼|PG147.68-2.70 (-1.80%) ▼|PLTR119.50-8.97 (-6.98%) ▼|PM173.17-5.23 (-2.93%) ▼|QCOM221.90-4.21 (-1.86%) ▼|RTX181.83-3.77 (-2.03%) ▼|SBUX100.15-0.50 (-0.50%) ▼|SCHW92.03+0.33 (+0.36%) ▲|SO93.43+0.34 (+0.37%) ▲|SPG214.57+3.24 (+1.53%) ▲|T22.10+0.09 (+0.41%) ▲|TMO464.01-0.60 (-0.13%) ▼|TMUS180.06-1.61 (-0.89%) ▼|TSLA405.05+4.56 (+1.14%) ▲|TXN332.28+9.42 (+2.92%) ▲|UBER71.43-0.21 (-0.29%) ▼|UNH406.68+5.72 (+1.43%) ▲|UNP259.91+3.03 (+1.18%) ▲|UPS107.24+2.38 (+2.27%) ▲|USB58.68+0.54 (+0.93%) ▲|V326.60-0.64 (-0.20%) ▼|VZ45.36-0.01 (-0.02%) ▼|WFC83.84+1.64 (+2.00%) ▲|WMT117.18+0.00 (+0.00%) ▲|XOM138.47+0.66 (+0.48%) ▲|
20.7 C
New York
Tuesday, June 23, 2026

Tag: FDA

newssourceFORcompanyinformationcontent1marketreleases

Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%

New anti-colic system delivers clinically tested relief for newborn digestive discomfort BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care,...

Thyseed Is Set to Support Southeast Asian Families with Safer Infant Feeding Solutions, Powered by Medical-Grade Technology

BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care, recently announced plans to introduce its premium, safety-certified feeding solutions to...

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors

EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the appointment of Lucas Buchanan as a non-executive member of its Board of Directors.

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform

HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments and includes approval for its connected care platform marketed as 1Bio™.

Vitiligo Market to Register Incremental Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

The vitiligo market is witnessing steady growth due to rising disease awareness, improved diagnostic capabilities, and advancements in treatment options such as JAK inhibitors...

TYK2 Inhibitors Market to Drive Enormous Growth by 2034 Due to Strong Pipeline and Expanding Indications | DelveInsight

The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing prevalence of autoimmune diseases, robust clinical...

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its second quarter 2025 financial results after market close on Tuesday, August 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update.

Cryoport Reports Second Quarter 2025 Financial Results

Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 millionLife Sciences Services revenue rose...

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Targeting Multi-Chain Digital Asset Growth and Decentralized Finance (DeFi) Integration

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth

CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them

Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells 
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells

Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1

OSLO, Norway, Aug. 5, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, today announced that the U.S....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFDA

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers